Brooks Laboratories Ltd (BROOKS)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 146.80
% Change: -1.92% (Prev Close: 149.68)

Volume: 32,049
% Change: -45.39% (Prev Volume: 58,687)

Delivery: 22,849
Delivery % : 71.29
% Change: -48.42% (Prev Delivery: 44,298)

Turnover: 47 Lacs
% Change: -46.48% (Prev Turnover: 87)

πŸ’Ή EOD Valuation

P/E Ratio: 333.64
P/B Ratio: 4.41
Market Cap: 433 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: BROOKS
Market Cap: 397 Rs. Cr.
Face Value: 10.00 Rs.

52 Week High: 202.80
52 Week Low: 95.55

All-Time High: 202.80 Rs.
All-Time Low: 10.29 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-12.28% | 4.28% | 19.78% | 12.78% | 0.88%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 52.62%

Change (3Y | 1Y): -13.79% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 0.00%

Change (3Y | 1Y): 0.00% | -0.05%

DII Holding

DII Holding: 10.38%

Change (3Y | 1Y): 10.38% | 0.00%

Public Holding: 37.00%

🏦 Financial Strength

Debt to Equity: 0.08
Debt: 7.58 Rs. Cr.

Book Value: 33.31 Rs.
Current Ratio: 1.48
Interest Coverage: 2.91
Free Cash Flow: 1.61 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 10.30%

Sales Growth Qtr (YOY | QoQ):
42.28% | 9.39%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | -3.26% | 10.30%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 111.57%

Profit Growth Qtr (YOY | QoQ):
497.51% | 756.16%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
0.00% | 3.94% | 111.57%

EPS Rs.

EPS (TTM): 0.44 Rs.

EPS Qtr (Last Year | Latest):
-0.92 Rs. | 3.25 Rs.

EPS Annual (Last Annual | Annual March):
-7.46 Rs. | -3.38 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
0.00% | 6.85%

Net Profit Rs. Cr.

Net Profit (TTM): 2.03 Rs. Cr.

Net Profit (Annual - March): -9.97 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
-2.41| -1.46 | 9.58

EBITDA Rs. Cr.

EBITDA (Quarter): 10.28 Rs. Cr.
EBITDA (Previous Yr Ql): -1.85 Rs. Cr.

EBITDA (Annual - March): -7.16 Rs. Cr.
EBITDA (Previous Annual): -16.96 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
0.00% | 13.77%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): -3.37%

OPM Qtr (Previous | Current):
-5.40% | 12.27%

OPM Annual (5 Yrs | Last Yr | March):
-17.62% | -22.53% | -9.74%

Return on Equity %

ROE: -12.18%

ROE (5 Yrs | 3 Yrs | Last Yr):
0.00% | -21.82% | -28.09%

Return on Capital Employed %

ROCE: -9.90%

ROCE (5 Yrs | 3 Yrs | Last Yr):
-20.14% | -21.68% | -24.70%

Return on Assets %

ROA (TTM): -9.31%

ROA (5 Yrs | 3 Yrs | Last Yr):
0.00% | -16.49% | -19.60%

PEG Ratio: 49.61
Dividend Yield: 0.00%

PE 3 Yrs: 332.18
PE 5 Yrs: 332.18

Dividend Yield: 0.00%

πŸ‘₯ Company

Brooks Laboratories Ltd

BROOKS

Promoter Holding: %